Cargando…

Significance of microRNA-related variants in susceptibility to recurrence of oropharyngeal cancer patients after definitive radiotherapy

Common single nucleotide polymorphisms (SNPs) in miRNAs may affect miRNA functions and their target expression and thus may affect biological activities and cancer etiology as well as prognosis. Thus, we determined whether the 9 SNPs in microRNAs modify the risk of recurrence of squamous cell carcin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Xingming, Sturgis, Erich M., Wang, Chengyuan, Cao, Xiaoli, Li, Yuncheng, Wei, Qingyi, Li, Guojun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085206/ https://www.ncbi.nlm.nih.gov/pubmed/27145460 http://dx.doi.org/10.18632/oncotarget.9014

Ejemplares similares

A functional variant at miRNA-122 binding site in IL-1α 3′ UTR predicts risk of recurrence in patients with oropharyngeal cancer
por: Wang, Chengyuan, et al.
Publicado: (2016)

The Modifying Effect of a Functional Variant at the miRNA Binding Site in E2F1 Gene on Recurrence of Oropharyngeal Cancer Patients with Definitive Radiotherapy
por: Zhang, Hua, et al.
Publicado: (2018)

Pre-miRNA variants as predictors of clinical outcome in patients with squamous cell carcinomas of the nonoropharynx
por: Wang, Chengyuan, et al.
Publicado: (2016)

Modifying effect of mouse double minute-2 promoter variants on risk of recurrence for patients with squamous cell carcinoma of oropharynx
por: Zhang, Yang, et al.
Publicado: (2017)

GWAS-identified telomere length associated genetic variants predict risk of recurrence of HPV-positive oropharyngeal cancer after definitive radiotherapy
por: Sun, Peng, et al.
Publicado: (2023)

Association of Combined p73 and p53 Genetic Variants with Tumor HPV16-Positive Oropharyngeal Cancer
por: Wang, Zhongqiu, et al.
Publicado: (2012)

MicroRNA Variants Increase the Risk of HPV-Associated Squamous Cell Carcinoma of the Oropharynx in Never Smokers
por: Song, Xicheng, et al.
Publicado: (2013)

Genetic Variation in MDM2 and p14 (ARF) and Susceptibility to Salivary Gland Carcinoma
por: Jin, Lei, et al.
Publicado: (2012)

Regional recurrence of oropharyngeal cancer after definitive radiotherapy: a case control study
por: Söderström, Karin, et al.
Publicado: (2015)

Prognostic significance of pre-treatment neutrophil-to-lymphocyte ratio (NLR) in patients with oropharyngeal cancer treated with radiotherapy
por: Ng, Sweet Ping, et al.
Publicado: (2020)

Genetic susceptibility to patient-reported xerostomia among long-term oropharyngeal cancer survivors
por: Aggarwal, Puja, et al.
Publicado: (2022)

Prognostic impact of leukocyte counts before and during radiotherapy for oropharyngeal cancer
por: Jensen, Garrett L., et al.
Publicado: (2017)

Genetic variants of NOXA and MCL1 modify the risk of HPV16-associated squamous cell carcinoma of the head and neck
por: Zhou, Ziyuan, et al.
Publicado: (2012)

A Radiomics-Based Classifier for the Progression of Oropharyngeal Cancer Treated with Definitive Radiotherapy
por: Garcia, Darwin A., et al.
Publicado: (2023)

Association between a rare novel TP53 variant (rs78378222) and melanoma, squamous cell carcinoma of head and neck and lung cancer susceptibility in non-Hispanic Whites
por: Guan, Xiaoxiang, et al.
Publicado: (2013)

Genome-scale identification of microRNA-related SNPs associated with risk of head and neck squamous cell carcinoma
por: Wilkins, Owen M, et al.
Publicado: (2017)

Association of tumor necrosis factor-alpha promoter variants with risk of HPV-associated oral squamous cell carcinoma
por: Jin, Lei, et al.
Publicado: (2013)

Survival impact of pre-treatment neutrophils on oropharyngeal and laryngeal cancer patients undergoing definitive radiotherapy
por: Sumner, Whitney A., et al.
Publicado: (2017)

Site disparities in apoptotic variants as predictors of risk for second primary malignancy in patients with squamous cell carcinoma of the head and neck
por: Sun, Yan, et al.
Publicado: (2016)

Role of human papillomavirus and cell cycle-related variants in squamous cell carcinoma of the oropharynx
por: Li, Guojun, et al.
Publicado: (2010)

Genetic variants of p27 and p21 as predictors for risk of second primary malignancy in patients with index squamous cell carcinoma of head and neck
por: Wang, Zhongqiu, et al.
Publicado: (2012)

Concordance of oral HPV prevalence between patients with oropharyngeal cancer and their partners
por: Tsao, Anne S., et al.
Publicado: (2016)

Neutrophil-lymphocyte ratio complements volumetric staging as prognostic factor in patients treated with definitive radiotherapy for oropharyngeal cancer
por: Panje, Cédric, et al.
Publicado: (2017)

Identification of a six microRNA signature as a novel potential prognostic biomarker in patients with head and neck squamous cell carcinoma
por: Shi, Hao, et al.
Publicado: (2016)

[18F]Fluorodeoxyglucose uptake by positron emission tomography predicts outcomes for oropharyngeal and hypopharyngeal cancer treated with definitive radiotherapy
por: Ishihara, Takeaki, et al.
Publicado: (2017)

Correlation of immune makers with HPV 16 infections and the prognosis in oropharyngeal squamous cell carcinoma
por: Zhu, Yingying, et al.
Publicado: (2023)

Association between novel PLCE1 variants identified in published esophageal cancer genome-wide association studies and risk of squamous cell carcinoma of the head and neck
por: Ma, Hongxia, et al.
Publicado: (2011)

Targeting MicroRNAs in Prostate Cancer Radiotherapy
por: Ni, Jie, et al.
Publicado: (2017)

Diagnostic significance of microRNAs in sepsis
por: Zheng, Xiaolan, et al.
Publicado: (2023)

An economic and disease transmission model of human papillomavirus and oropharyngeal cancer in Texas
por: Zhong, Chengxue, et al.
Publicado: (2021)

PARP inhibitor Olaparib increases the sensitization to radiotherapy in FaDu cells
por: Liu, Chuan, et al.
Publicado: (2020)

Risk of second primary malignancies in head and neck cancer patients treated with definitive radiotherapy
por: Ng, Sweet Ping, et al.
Publicado: (2019)

Re-irradiation of recurrent esophageal cancer after primary definitive radiotherapy
por: Kim, Young Suk, et al.
Publicado: (2012)

Carbon ion radiotherapy as definitive treatment in locally recurrent pancreatic cancer
por: Liermann, Jakob, et al.
Publicado: (2021)

Salivary Exosomal MicroRNA-486-5p and MicroRNA-10b-5p in Oral and Oropharyngeal Squamous Cell Carcinoma
por: Faur, Cosmin Ioan, et al.
Publicado: (2022)

Clinical significance of local control of primary tumour in definitive radiotherapy for scalp angiosarcomas
por: Kashihara, Tairo, et al.
Publicado: (2022)

The Role of MicroRNAs in Cancer Susceptibility
por: Iuliano, Rodolfo, et al.
Publicado: (2013)

Prognostic factors, patterns of recurrence and toxicity for patients with esophageal cancer undergoing definitive radiotherapy or chemo-radiotherapy
por: Haefner, Matthias F., et al.
Publicado: (2015)

Survival Outcomes and Patterns of Recurrence in Patients with Stage III or IV Oropharyngeal Cancer Treated with Primary Surgery or Radiotherapy
por: Debenham, Brock J, et al.
Publicado: (2016)

MicroRNAs in the Blood-Brain Barrier in Hypoxic-Ischemic Brain Injury
por: Shen, Guofang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cdtd8bsrb745mfj68ahuu3111b